Here are relevant reports on : market-research-services-market
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017
The Latin American bioinformatics market was valued at $242 million in 2012 and is poised to reach $627 million by 2017, at a CAGR of 22%. The Latin American bioinformatics market displays lucrative growth potential. It is propelled by the rising number of training and development programs on usage of bioinformatics tools, which leads to an increase in the use of bioinformatics tools by industrial and academic bioinformaticians in life sciences research. In addition, the market is further driven by the high concentration of bioinformatics research institutes in Latin America that aim to facilitate the use of bioinformatics in life sciences research. However, the dearth of skilled personnel and facilities to ensure the proper use of bioinformatics products and services and the dearth of advanced and innovative bioinformatics tools and algorithms are limiting the growth of the bioinformatics market in Latin America.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2028
The global particle therapy market, valued at US$0.6 billion in 2022, stood at US$0.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.2% from 2023 to 2028, culminating in a forecasted valuation of US$1.1 billion by the end of the period. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key market players in developing regions are driving the growth of the particle therapy market
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Hydrophobic Interaction Chromatography Market by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes) - Global Forecast to 2023
The global hydrophobic interaction chromatography market is projected to reach USD 418.2 million in 2023 from USD 271.0 million in 2017, at a CAGR of 7.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. In the current market scenario, there is a growing demand for hydrophobic interaction chromatography. The major factors driving the growth of this market are the increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals. The key players in the global hydrophobic interaction chromatography market are GE Healthcare (US), Bio-Rad Laboratories (US), Sartorius (Germany), and Thermo Fisher Scientific (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market size is projected to grow at a CAGR of 12.3%. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Long Read Sequencing Market by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029
The global long-read sequencing market, valued at US$596 million in 2023, stood at US$758 million in 2024 and is projected to advance at a resilient CAGR of 32.8% from 2024 to 2029, culminating in a forecasted valuation of US$3,129 million by the end of the period. The main forces behind the growth of this market are the rising frequency of complex genetic disorders, expanding applications of long-read sequencing, and the technological development in genome sequencing aiding in the adoption of third-generation sequencing.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025
The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029
The global protein expression market, valued at US$3.34 billion in 2023, stood at US$3.41 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$4.82 billion by the end of the period. This growth is driven by the increasing demand for biologics, rising R&D investments in the pharmaceutical and biopharmaceutical sectors, and the growing use of artificial intelligence and machine learning to improve protein structure and function predictions.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030
The global contract research organization (CRO) services market, valued at US$79.10 billion in 2024, stood at US$84.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$125.95 billion by the end of the period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market.
- Published: September 2025
- Price: $ 7150
- TOC Available:
Records 11 to 20 of 50
